Effects of changes in basal/total daily insulin ratio in type 2 diabetes patients on intensive insulin therapy including insulin glargine (JUN-LAN Study 6)

Diabetes Research and Clinical Practice

Volumn 81, Issue 2, 2008, Pages

  Tamaki, Motoyuki ^a   Shimizu, Tomoaki ^a   Kanazawa, Akio ^a   Fujitani, Yoshio ^a,b   Watada, Hirotaka ^a   Kawamori, Ryuzo ^a,b   Hirose, Takahisa ^a,b  

^a JUNTENDO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b JUNTENDO UNIVERSITY   (Japan)

Author keywords

Basal and bolus insulin; Insulin glargine; Rapid acting insulin; Type 2 diabetes

Indexed keywords

GLYCOSYLATED ALBUMIN; INSULIN; INSULIN GLARGINE;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG DOSE INCREASE; DRUG DOSE REDUCTION; HUMAN; INSULIN BLOOD LEVEL; INSULIN RELEASE; INSULIN TREATMENT; JAPANESE; NON INSULIN DEPENDENT DIABETES MELLITUS; POSTPRANDIAL STATE; TREATMENT DURATION;

DIABETES MELLITUS, TYPE 2; DOSE-RESPONSE RELATIONSHIP, DRUG; GLYCOSYLATION; HUMANS; HYPOGLYCEMIC AGENTS; INSULIN; INSULIN, ISOPHANE; SERUM ALBUMIN;

EID: 47649097531     PISSN: 01688227     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.diabres.2008.03.021     Document Type: Article

References (5)

1. Nathan D.M., Buse J.B., Davidson M.B., Heine R.J., Holman R.R., Sherwin R., et al. Management of hyperglycemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy: a consensus statement from the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care 29 (2006) 1963-1972
2. Nathan D.M., Buse J.B., Davidson M.B., Heine R.J., Holman R.R., Sherwin R., et al. Management of hyperglycemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy: a consensus statement from the American Diabetes Association and the European Association for the Study of Diabetes. Diabetologia 49 (2006) 1711-1721
3. Takamura T., Shimizu A., and Kaneko A.H. Comment on: D.M. Nathan, J.B. Buse, M.B. Davidson, et al. (2006), Management of hyperglycemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy: a consensus statement from the American Diabetes Association and the European Association for the Study of Diabetes. Diabetologia 49: 1711-1721. Diabetologia 50 (2007) 229-230
4. Kanazawa Y., Igarashi Y., Komiya K., Sakurai Y., Shimizu T., Fujitani Y., et al. Long term efficacy of insulin glargine switched from NPH insulin as intensive replacement of basal insulin in Japanese diabetes mellitus-comparison of efficacy between type 1 and type 2 diabetes (JUN-LAN Study 1.2). Endocr. J. 54 (2007) 975-983
5. Yokoyama H., Tada J., Kamikawa F., Kanno S., Yokota Y., and Kuramitsu M. Efficacy of conversion from bedtime NPH insulin to morning insulin glargine in type 2 diabetic patients on basal-prandial insulin therapy. Diabetes Res. Clin. Pract. 73 (2006) 35-40